Screening for left ventricular systolic dysfunction: Is imaging a solution?

JACC: Cardiovascular Imaging

Volumn 3, Issue 4, 2010, Pages 421-428

  Atherton, John J ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

diagnosis; heart failure; screening y ventricular dysfunction

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NATRIURETIC FACTOR; BIOLOGICAL MARKER;

CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DRUG EFFICACY; ECHOCARDIOGRAPHY; HEALTH CARE UTILIZATION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE FUNCTION; HIGH RISK POPULATION; HUMAN; IMAGE QUALITY; INTRACARDIAC ECHOCARDIOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; RECEIVER OPERATING CHARACTERISTIC; REVIEW; SCORING SYSTEM; SCREENING; ADULT; AGED; BLOOD; EARLY DIAGNOSIS; ECHOGRAPHY; ELECTROCARDIOGRAPHY; EQUIPMENT DESIGN; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; INSTRUMENTATION; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MORTALITY; PREDICTION AND FORECASTING; PROGNOSIS; PROGRAM DEVELOPMENT;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EQUIPMENT DESIGN; HEART FAILURE; HUMANS; MASS SCREENING; MIDDLE AGED; NATRIURETIC PEPTIDES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROGRAM DEVELOPMENT; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77954677427     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2009.11.014     Document Type: Review

References (40)

1. V.L. Roger, S.A. Weston, and M.M. Redfield Trends in heart failure incidence and survival in a community-based population JAMA 292 2004 344 350
2. P.A. McCullough, E.F. Philbin, J.A. Spertus, S. Kaatz, K.R. Sandberg, and W.D. Weaver Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study J Am Coll Cardiol 39 2002 60 69
3. G. de Simone, J.S. Gottdiener, M. Chinali, and M.S. Maurer Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study Eur Heart J 29 2008 741 747
4. Y. Takemoto, M.E. Barnes, and J.B. Seward Usefulness of left atrial volume in predicting first congestive heart failure in patients > or = 65 years of age with well-preserved left ventricular systolic function Am J Cardiol 96 2005 832 836
5. G.P. Aurigemma, J.S. Gottdiener, L. Shemanski, J. Gardin, and D. Kitzman Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the Cardiovascular Health Study J Am Coll Cardiol 37 2001 1042 1048
6. H.V. Fineberg, R. Bauman, and M. Sosman Computerized cranial tomography Effect on diagnostic and therapeutic plans JAMA 238 1977 224 227
7. G.S. Gazelle, P.M. McMahon, U. Siebert, and M.T. Beinfeld Cost-effectiveness analysis in the assessment of diagnostic imaging technologies Radiology 235 2005 361 370
8. P.S. Douglas, A. Taylor, and D. Bild Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute J Am Coll Cardiol Img 2 2009 897 907
9. S.J. Lord, L. Irwig, and R.J. Simes When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials? Ann Intern Med 144 2006 850 855
10. K.A. Ammar, S.J. Jacobsen, and D.W. Mahoney Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community Circulation 115 2007 1563 1570
11. R. Kelly, and A.D. Struthers Screening for left ventricular systolic dysfunction in patients with stroke, transient ischaemic attacks, and peripheral vascular disease QJM 92 1999 295 297
12. T.J. Wang, J.C. Evans, E.J. Benjamin, D. Levy, E.C. LeRoy, and R.S. Vasan Natural history of asymptomatic left ventricular systolic dysfunction in the community Circulation 108 2003 977 982
13. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions The SOLVD Investigators N Engl J Med 327 1992 685 691
14. S.A. Hunt, W.T. Abraham, and M.H. Chin 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, developed in collaboration with the International Society for Heart and Lung Transplantation J Am Coll Cardiol 53 2009 e1 e90
15. P. Jong, S. Yusuf, M.F. Rousseau, S.A. Ahn, and S.I. Bangdiwala Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study Lancet 361 2003 1843 1848
16. S.F. Ho, M.S. O'Mahony, J.A. Steward, M.L. Burr, and M. Buchalter Left ventricular systolic dysfunction and atrial fibrillation in older people in the communitya need for screening? Age Ageing 33 2004 488 492
17. J.M. Gardin, D. Siscovick, and H. Anton-Culver Sex, age, and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly The Cardiovascular Health Study Circulation 91 1995 1739 1748
18. R.B. Devereux, M.J. Roman, and M. Paranicas A population-based assessment of left ventricular systolic dysfunction in middle-aged and older adults: the Strong Heart Study Am Heart J 141 2001 439 446
19. T.A. McDonagh, C.E. Morrison, and A. Lawrence Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population Lancet 350 1997 829 833
20. H. Schunkert, U. Broeckel, H.W. Hense, U. Keil, and G.A. Riegger Left-ventricular dysfunction Lancet 351 1998 372
21. A. Mosterd, A.W. Hoes, and M.C. de Bruyne Prevalence of heart failure and left ventricular dysfunction in the general population: the Rotterdam Study Eur Heart J 20 1999 447 455
22. M. Davies, F. Hobbs, and R. Davis Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening Study: a population based study Lancet 358 2001 439 444
23. M.M. Redfield, S.J. Jacobsen, J.C. Burnett Jr., D.W. Mahoney, K.R. Bailey, and R.J. Rodeheffer Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic JAMA 289 2003 194 202
24. W.P. Abhayaratna, W.T. Smith, N.G. Becker, T.H. Marwick, I.M. Jeffery, and D.A. McGill Prevalence of heart failure and systolic ventricular dysfunction in older Australians: the Canberra Heart Study Med J Aust 184 2006 151 154
25. V. Madhok, G. Falk, A. Rogers, A.D. Struthers, F.M. Sullivan, and T. Fahey The accuracy of symptoms, signs and diagnostic tests in the diagnosis of left ventricular dysfunction in primary care: a diagnostic accuracy systematic review BMC Fam Pract 9 2008 56
26. R.S. Vasan, E.J. Benjamin, and M.G. Larson Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham Heart Study JAMA 288 2002 1252 1259
27. C. Davenport, E.Y. Cheng, and Y.T. Kwok Assessing the diagnostic test accuracy of natriuretic peptides and ECG in the diagnosis of left ventricular systolic dysfunction: a systematic review and meta-analysis Br J Gen Pract 56 2006 48 56
28. B. Ewald, D. Ewald, A. Thakkinstian, and J. Attia Meta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction Intern Med J 38 2008 101 113
29. J. Latour-Perez, F.J. Coves-Orts, C. Abad-Terrado, V. Abraira, and J. Zamora Accuracy of B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction and heart failure: a systematic review Eur J Heart Fail 8 2006 390 399
30. M. Nakamura, H. Endo, M. Nasu, N. Arakawa, T. Segawa, and K. Hiramori Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population Heart 87 2002 131 135
31. P.A. Heidenreich, M.A. Gubens, G.C. Fonarow, M.A. Konstam, L.W. Stevenson, and P.G. Shekelle Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction J Am Coll Cardiol 43 2004 1019 1026
32. M.M. Redfield, R.J. Rodeheffer, S.J. Jacobsen, D.W. Mahoney, K.R. Bailey, and J.C. Burnett Jr. Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study Circulation 109 2004 3176 3181
33. L.L. Ng, B. Pathik, I.W. Loke, I.B. Squire, and J.E. Davies Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure Am Heart J 152 2006 94 101
34. L.L. Ng, I.W. Loke, and J.E. Davies Community screening for left ventricular systolic dysfunction using plasma and urinary natriuretic peptides J Am Coll Cardiol 45 2005 1043 1050
35. K.T. Spencer, A.S. Anderson, and A. Bhargava Physician-performed point-of-care echocardiography using a laptop platform compared with physical examination in the cardiovascular patient J Am Coll Cardiol 37 2001 2013 2018
36. E.C. Vourvouri, A.F. Schinkel, and J.R. Roelandt Screening for left ventricular dysfunction using a hand-carried cardiac ultrasound device Eur J Heart Fail 5 2003 767 774
37. G.I. Galasko, A. Lahiri, and R. Senior Portable echocardiography: an innovative tool in screening for cardiac abnormalities in the community Eur J Echocardiogr 4 2003 119 127
38. G.I. Galasko, S.C. Barnes, P. Collinson, A. Lahiri, and R. Senior What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination? Eur Heart J 27 2006 193 200
39. J.H. Alexander, E.D. Peterson, A.Y. Chen, T.M. Harding, D.B. Adams, and J.A. Kisslo Jr. Feasibility of point-of-care echocardiography by internal medicine house staff Am Heart J 147 2004 476 481
40. J.N. Kirkpatrick, V. Belka, and K. Furlong Effectiveness of echocardiographic imaging by nurses to identify left ventricular systolic dysfunction in high-risk patients Am J Cardiol 95 2005 1271 1272